RM

Ramakrishna Malakalapalli

Active Director Director DIN 08814479
DIN 08814479 First appointment Jul 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramakrishna Malakalapalli

Data last updated:

Ramakrishna Malakalapalli is a Director at Southernpine Nutraceuticals India Private Limited (since 2020). The company operates in Chemicals.

DIN 08814479
Primary Designation Director
Industry Chemicals
First Appointment 29 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Jul 20202020Active

Board colleagues of Ramakrishna Malakalapalli

Directorship timeline

Open interactive timeline →
Southernpine Nutraceuticals India Private Limited
Premium access

Shareholding and investment profile for Ramakrishna Malakalapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishna Malakalapalli

Ramakrishna Malakalapalli currently holds 1 directorship: Southernpine Nutraceuticals India Private Limited (Director, since 29 Jul 2020).

Ramakrishna Malakalapalli was first appointed on 29 Jul 2020 as Director at Southernpine Nutraceuticals India Private Limited.

The current boards of Ramakrishna Malakalapalli's companies include Guna Vidya Saraswathi Boppana (Southernpine Nutraceuticals India Private Limited), Vinod Kumar Boppana (Southernpine Nutraceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available